{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:41:42Z","timestamp":1791319302360,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.seizure.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T14:16:10Z","timestamp":1504966570000},"page":"53-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Factors associated with occurrence and outcome of super-refractory status epilepticus"],"prefix":"10.1016","volume":"52","author":[{"given":"Dominik","family":"Mad\u017ear","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben U.","family":"Knappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Giede-Jeppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian I.","family":"Spr\u00fcgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Beuscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Gollwitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajo M.","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen B.","family":"Huttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.seizure.2017.09.003_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/1743132812Y.0000000128","article-title":"Refractory status epilepticus: new insights in presentation, treatment, and outcome","volume":"35","author":"Hocker","year":"2013","journal-title":"Neurol Res"},{"issue":"Pt. 8","key":"10.1016\/j.seizure.2017.09.003_bib0010","first-page":"2314","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Ferlisi","year":"2012","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.seizure.2017.09.003_bib0015","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archneur.62.9.1428","article-title":"A malignant variant of status epilepticus","volume":"62","author":"Holtkamp","year":"2005","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2017.09.003_bib0020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12028-013-9823-4","article-title":"Clinical outcomes following prolonged refractory status epilepticus (PRSE)","volume":"18","author":"Kilbride","year":"2013","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2017.09.003_bib0025","article-title":"Refractory and super-refractory status epilepticus in adults: a 9-year cohort study","author":"Delaj","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2017.09.003_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13054-015-0914-9","article-title":"Functional outcome of prolonged refractory status epilepticus","volume":"19","author":"Lai","year":"2015","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.seizure.2017.09.003_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"issue":"8","key":"10.1016\/j.seizure.2017.09.003_bib0040","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0196-0644(05)80120-9","article-title":"Refractory status epilepticus in adults","volume":"22","author":"Jagoda","year":"1993","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.seizure.2017.09.003_bib0045","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1528-1157.1993.tb00433.x","article-title":"Guidelines for epidemiologic studies on epilepsy. Commission on epidemiology and prognosis, international league against epilepsy","volume":"34","year":"1993","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2017.09.003_bib0050","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","article-title":"Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation","volume":"77","author":"Rossetti","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.seizure.2017.09.003_bib0055","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","article-title":"Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy","volume":"255","author":"Rossetti","year":"2008","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2017.09.003_bib0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003693305700200504","article-title":"Cerebral vascular accidents in patients over the age of 60. II. Prognosis","volume":"2","author":"Rankin","year":"1957","journal-title":"Scott Med J"},{"issue":"Suppl. 4","key":"10.1016\/j.seizure.2017.09.003_bib0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1528-1167.2012.03622.x","article-title":"Causes of status epilepticus","volume":"53","author":"Trinka","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2017.09.003_bib0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ene.12531","article-title":"Early predictors of refractory status epilepticus: an international two-center study","volume":"22","author":"Sutter","year":"2015","journal-title":"Eur J Neurol"},{"issue":"12","key":"10.1016\/j.seizure.2017.09.003_bib0075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.seizure.2017.09.003_bib0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur J Neurol"},{"issue":"11","key":"10.1016\/j.seizure.2017.09.003_bib0085","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/01.wnl.0000223352.71621.97","article-title":"A clinical score for prognosis of status epilepticus in adults","volume":"66","author":"Rossetti","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.09.003_bib0090","article-title":"Pathophysiology of status epilepticus","author":"Walker","year":"2016","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.seizure.2017.09.003_bib0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2017.09.003_bib0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2016.04.036","article-title":"Interleukin-1 receptor is a target for adjunctive control of diazepam-refractory status epilepticus in mice","volume":"328","author":"Xu","year":"2016","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.seizure.2017.09.003_bib0105","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/epi.13625","article-title":"Decreased allopregnanolone levels in cerebrospinal fluid obtained during status epilepticus","volume":"58","author":"Meletti","year":"2017","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.seizure.2017.09.003_bib0110","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1161\/STROKEAHA.112.670422","article-title":"Prestroke modified rankin stroke scale has moderate interobserver reliability and validity in an acute stroke setting","volume":"43","author":"Fearon","year":"2012","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.seizure.2017.09.003_bib0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.seizure.2017.09.003_bib0120","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1097\/CCM.0b013e3182591ff1","article-title":"Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation","volume":"40","author":"Kowalski","year":"2012","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.seizure.2017.09.003_bib0125","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1528-1167.2012.03576.x","article-title":"Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study","volume":"53","author":"Sutter","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2017.09.003_bib0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/WNP.0000000000000223","article-title":"Is favorable outcome possible after prolonged refractory status epilepticus?","volume":"33","author":"Alvarez","year":"2016","journal-title":"J Clin Neurophysiol"},{"issue":"12","key":"10.1016\/j.seizure.2017.09.003_bib0135","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/archneurol.2009.273","article-title":"Functional and cognitive outcome in prolonged refractory status epilepticus","volume":"66","author":"Cooper","year":"2009","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2017.09.003_bib0140","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1528-1167.2008.01993.x","article-title":"Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours","volume":"50","author":"Drislane","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2017.09.003_bib0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1994.tb02908.x","article-title":"Determinants of mortality in status epilepticus","volume":"35","author":"Towne","year":"1994","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2017.09.003_bib0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40263-017-0424-1","article-title":"Newer antiepileptic drugs in status epilepticus: prescription trends and outcomes in comparison with traditional agents","volume":"31","author":"Beuchat","year":"2017","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.seizure.2017.09.003_bib0155","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/j.1528-1167.2011.03327.x","article-title":"Good outcome is possible after months of refractory convulsive status epilepticus: lesson learned","volume":"53","author":"Standley","year":"2012","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117302820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117302820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:49:30Z","timestamp":1761011370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131117302820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":31,"alternative-id":["S1059131117302820"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2017.09.003","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with occurrence and outcome of super-refractory status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}